A carregar...

Glycogen Synthase Kinase-3: A Promising Therapeutic Target for Fragile X Syndrome

Recent advances in understanding the pathophysiological mechanisms contributing to fragile X syndrome (FXS) have increased optimism that drug interventions can provide significant therapeutic benefits. FXS results from inadequate expression of functional fragile X mental retardation protein (FMRP)....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mines, Marjelo A., Jope, Richard S.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Research Foundation 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3205455/
https://ncbi.nlm.nih.gov/pubmed/22053151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnmol.2011.00035
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!